|
|
.
NPI Detail
NPI: 1811946734
Type: Organization
Taxonomy Code: 261QI0500X
2825 XXXXXXX XXXXXX
SACRAMENTO, CA 958165616
Mailing and Business location phone:
(XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1811946734*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXXX.XX
|
| 84443
|
ASSAY THYROID STIM HORMONE
|
XXXXX
|
$XXXXXX.XX
|
| 80061
|
LIPID PANEL
|
XXXXX
|
$XXXXXX.XX
|
| 80048
|
METABOLIC PANEL TOTAL CA
|
XXXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J2704
|
Inj, propofol, 10 mg
|
XXXXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXXX
|
$XXXXXX.XX
|
| J2795
|
Ropivacaine hcl injection
|
XXXXXX
|
-
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXX
|
$XXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
| J2001
|
Lidocaine injection
|
XXXXX
|
-
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J1453
|
Fosaprepitant injection
|
XXXXX
|
$XXXX.XX
|
| J8540
|
Oral dexamethasone
|
XXXXX
|
-
|
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J0896
|
Inj luspatercept-aamt 0.25mg
|
XXXXX
|
$XXXXXX.XX
|
| J1644
|
Inj heparin sodium per 1000u
|
XXXXX
|
-
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
| J3262
|
Tocilizumab injection
|
XXXXX
|
$XXXXX.XX
|
| J0894
|
Decitabine injection
|
XXXXX
|
$XXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J7512
|
Prednisone ir or dr oral 1mg
|
XXXXX
|
-
|
| J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J3380
|
Injection, vedolizumab
|
XXXXX
|
$XXXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXX.XX
|
| J0878
|
Daptomycin injection
|
XXXXX
|
-
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J9349
|
Inj., tafasitamab-cxix
|
XXXXX
|
$XXXXXX.XX
|
| J0485
|
Belatacept injection
|
XXXXX
|
$XXXXX.XX
|
| J1301
|
Injection, edaravone, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J1745
|
Infliximab not biosimil 10mg
|
XXXXX
|
$XXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
